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Respiratory Simulator for Robotic Respiratory Tract
Treatments
Maria Elena Giannaccini1∗, Keren Yue1∗, James Graveston2, Martin Birchall3, Andrew Conn4 and Jonathan Rossiter1
Abstract—Robotic healthcare is a growing and multi-faceted
field where robots help perform surgery, remotely provide care
to patients, aid in supplying various physical therapies and fur-
ther medical research. Robotic simulators of human physiology
provide a powerful platform to advance the development of
novel treatments, prostheses and therapies. This study focuses
on the design, building, testing and characterisation of a novel
simulator of the human respiratory system. The comparison
between healthy subjects breathing and coughing physiological
values and the values achieved utilising our novel bioinspired
respiratory simulator shows that the latter is able to reproduce
peak flow rates and volumes.
Index Terms—simulator, respiratory system, robotic health-
care, bioinspiration
I. INTRODUCTION
Robotic physiology simulators such as artificial hearts and
prostheses provide a unique opportunity to exploit a wealth of
novel technologies and pave the way for robotic advancements
in healthcare. Such solutions not only help develop therapies
used to better the day-to-day lives of patients by providing
test-beds which reproduce the functionality of human organs
but also minimise the risk to human testers.
Respiratory diseases can potentially be life-threatening, as
is the case in pulmonary embolism, pneumonia, trauma, lung
cancer and acute asthma. Lung cancer amounted to 13% of
cancer cases in UK in 2014 [7]. Common treatments for some
of these diseases include excision and tracheotomy. Hence
robotic solutions are needed to provide better comfort, quality
of life and outcomes.
Simulators and models of the respiratory system possess
considerable utility in evaluating new robotic devices and
techniques, improving our understanding of the respiratory
system, guiding therapies and clinician education [9], test-
ing/trialling new treatments or pharmaceutics. A respiratory
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Fig. 1: Anterior view of the respiratory system [18].
simulator is either a physical or numerical platform which
reproduces human respiratory patterns.
Numerical simulations of airflow for breathing have used
MRI images to model the respiratory system from the nose
to the upper bronchi region [20]. Other studies have used CT
images and automatic meshing to compute the fluid dynamics
of pulmonary gas flow [12], have concentrated on oscillatory
flow in the laryngeal channel [16] or have studied power loss
mechanisms in pathological tracheas [1]. On the other hand,
physical apparatus that simulate the human respiratory system
have been developed to characterise particle delivery within
lungs [11] and to simulate specific lung pathologies [10].
None of these respiratory simulators feature anatomically
correct dimensioning of respiratory system physical structures
and multiple actuation systems, which are featured in our
design. In this work we present a new physical simulator that
aims to replicate the breathing and coughing characteristics
of healthy humans, providing a first-stage evaluative tool for
the development of robotic healthcare solutions for serious
respiratory conditions. The accurate simulation of respiration
in our benchtop platform will generate a platform for novel im-
plantable assistive devices and advanced treatment of bronchial
conditions such as asthma.
II. BIOINSPIRED ROBOTS IN HEALTHCARE
Bioinspiration is of extreme importance in the development
of robotic platforms aimed at simulating and testing the
behaviour of a biological structure. This is especially important
for the respiratory system which is such a vital component of
human life, and a delicate environment in which to develop
robotic healthcare treatment. For this reason we designed
our respiratory simulation platform so that it replicates the
dimensions and shape of the anatomy of the human respiratory
system as closely as possible (Fig. 1). The ability to reproduce
a physiological breathing pattern is chosen as a method of
testing and evaluating our simulator. First, experiments are
conducted on a number of healthy subjects to establish the
profile of physiological flow rate over time. Secondly, the
ability of the simulator to match the breathing profiles is
investigated. The experiments conducted on healthy subjects
are described in Section III. A description of the simulator
design and the experiments conducted on it is provided in
Section IV, where a comparison of the physiological profiles
with those obtained with the simulator is also provided.
Conclusions and future work are detailed in Section V.
III. BREATHING AND COUGHING IN HEALTHY SUBJECTS
A. Description of Hardware
A Sensirion SFM3000 flow meter was used to measure
normal breathing and deep breathing and a BioPac Pneu-
motachometer (TSD137H) was utilised to gather coughing
data. A disposable anti-viral and anti-bacterial filter prevented
contaminants from each participant from going into the flow
meter (Fig. 2). The data gathered with the Sensirion SFM3000
flow meter was collected utilising an Arduino Nano, while
the Biopac system utilises its own data acquisition system and
software.
B. Experiments
Breathing and coughing experiments were carried out with
8 healthy subjects within the age group of 25-40 years (ethics
approval was granted from Faculty of Engineering Ethics
committee, University of Bristol Ref:57763). All subjects
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Fig. 2: Devices used for experiments with subjects. The
filter is connected by an adaptor to the flow meter, which
communicates with the Arduino microcontroller.
followed the same experimental procedures. The subjects were
asked to perform three tasks:
1) Normal Breathing (Duration: 30-60s) The subjects are
asked to breath as naturally as they can.
2) Deep Breathing (Duration: 30-60s) The subjects are
asked to take a series of deep breaths.
3) Coughing (Cough 3 times) The subjects are asked to
take breath normally, then take a deep breath and then
cough as forcefully as they can.
Before beginning each test, subjects were asked to sit
down and relax for a few minutes to avoid artefacts in the
measurements due to any preceding aerobic activities.
C. Results
The average values and relative standard deviation for peak
flow rate and expiratory volume from the experiments are
shown in Table I. The mean frequency is 13±3 breaths/min
for normal breathing and 7±2 breaths/min for deep breathing.
Peak Flow Rate (L/min) Expiratory Volume (L)
Breathing 15.12 ± 3.18 0.46 ± 0.15
Deep Breathing 59.32 ± 22.69 1.40 ± 0.34
Coughing 538.42 ± 109.70 1.24 ± 0.18
TABLE I: Peak Flow Rate and Expiratory Volume obtained
from experiments
The flow rate values for breathing and for coughing found
in these experiments match the values reported in the liter-
ature [15], [2]. In order to test the ability of our simulator
in reproducing human physiological breathing and coughing
patterns, an example of both from the set of data acquired
was chosen. The representative example chosen for the normal
breathing experiment with human subjects is shown in Fig. 5
and the representative example chosen for the deep breathing
experiment with human subjects is shown in Fig. 7. The
simulator was then programmed to reproduce each of these
patterns.
As can be observed from Table I, Fig. 5 and Fig. 7, the flow
rate magnitude (60 L/min) for deep breathing is approximately
four times that of normal breathing (15 L/min). The coughing
profile can be seen in Fig. 11.
Flow Rate 
Sensor
Pressure 
Sensor
Fig. 3: Top view of the respiratory simulator system.
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Fig. 4: Lateral view of the respiratory simulator system.
IV. RESPIRATORY SIMULATOR
The respiratory simulator is designed by replicating as
closely as possible the dimensions, shape and function of
the human respiratory system in the hardware design. Each
human lung holds approximately three liters of air and this
is replicated in our system by two 3 liter syringes (see
Fig. 3). Anatomy literature is utilised to identify the average
anatomically-correct value for the angle of tracheal bifurcation
(approximately 70 degrees) [19], [14], [6], length (the average
length of the left bronchus is 47.8mm for men and 43.5mm
for women and the average length of the right bronchus
is 15.3mm for men and 13.2mm for women) and diameter
(the average diameter of bronchi in men is 12.9mm in the
left bronchus and 15.2mm in the right bronchus, the average
diameter of bronchi in women is 10.1mm in the left bronchus
and 12.5mm in the right bronchus) [13] of the simil-bronchi
component of our simulator. Similarly, the dimensions of the
trachea component of the simulator are matched to the values
(average diameter 17.07mm and average length 107.9mm)
found in anatomy literature [3], [5], [17] and [8]. Hence the
simulator system is designed to approximate a 1:1 replica of
the human respiratory system. Naturally, approximations are
made to simplify the physical design of the structure. One
of the main approximations made is that all components of
the simulator are rigid, contrary to the nature of the human
respiratory system, which is prevalently composed of soft and
compliant structures.
A. Description of Hardware
The simulator comprises five components: actuation system,
lungs, bronchi, trachea and glottis (Fig. 4). The actuation
system is an actuated linear guide (Zaber X-LSQ450B-E01)
fixed to the plungers of two 3 L calibration syringes (KoKo
KRS007) which imitate the function of lungs. Two flange
connectors secure the right hand side of the syringes to
the PLA 3D printed channels that imitate the bronchi. The
channels gradually reduce their diameter to the physiological
dimension of 12.7mm and converge into one channel at a
70 degrees angle between the two channels (which mirrors
the tracheal bifurcation, its physiological counterpart). This
simil-bronchi component is 29mm long. A further flange
connector connects the simil-bronchi component to a 19mm
internal diameter, 108mm long acrylic tube which imitates the
function of the trachea. A differential pressure sensor (SIP,
NB 015PD TruStability, Honeywell) is inserted into a hole
in the simil-trachea. A normally open, two port, solenoid
valve (SCE210C35-24VCC, Asco) imitates the opening and
closing function of the glottis. The TSD13717 BioPac flow
meter is fixed to the exhaust side of the solenoid valve. The
valve is powered through a relay which is controlled using a
DAQ (USB-6211, National Instruments), which also collects
the measurements from the pressure sensor. The system is
controlled via MATLAB2017®, which is also used for the
data post-processing.
The working principle of the simulator is repeatable and
robust: the computer-controlled actuated linear guide is used to
replicate the movement of the human diaphragm and generates
the force needed to drive the syringes. The air is then pushed
through the simil-bronchi and simil-trachea components. In
the case of breathing, the solenoid valve is kept open and the
breathing flow rate is measured with the BioPac flow meter
attached to the exhaust side of the valve. The simulation of a
cough comprises four stages: 1) the solenoid valve is closed,
2) the actuated linear guide compresses air in the system
until 3) the pressure sensor registers a pressure above a fixed
threshold; this triggers 4) the opening of the valve which
causes the exhalation of the compressed air. The peak flow
rate is measured by the BioPac flow meter.
B. Breathing Experiments
The tidal volume (TV, volume of air displaced between
inhalation and exhalation in normal breathing) is utilised as
a starting point in simulating the human breathing pattern.
TV is calculated by identifying the flow rate data obtained in
the experiments described in Section III. Since the volume of
the syringes is known, a simple proportion yields the syringe
plunger travel needed to obtain the same volumetric flow as
in the physiological experiment. Flow rates and acceleration
are identified utilising an iterative process.
C. Results
Fig. 6 shows simulated flow profiles replicating the normal
breathing in Fig. 5. Fig. 8 shows simulated flow profiles
replicating deep breathing in Fig. 7. The simulator is able to
reproduce both the breathing TV of 0.35L and deep breathing
TV of 1.5L. The complexity of the physiological profile is not
fully reproduced by the simulator.
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Fig. 5: Normal human breathing.
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Fig. 6: Simulator breathing.
However, the maximum flow rate is replicated in both exper-
iments, together with the inspiration and expiration duration.
The overall flow profile provides the important prototypical
and highly repeatable respiratory function needed for robotic
device development and testing. The simulator successfully
attains the reproduction of a simplified breathing and deep
breathing pattern.
D. Coughing Experiments
Coughing is a defence mechanism comprising three phases:
(i) an inspiratory phase, (ii) a forced expiration against a closed
glottis, (iii) opening of the glottis followed by fast exhalation,
which results in a cough sound [4]. Experiments aimed at
reproducing coughing are conducted by specifying the travel
distance, velocity and acceleration for the linear guide, which
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Fig. 7: Human deep breathing.
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Fig. 8: Simulator deep breathing.
pushes the syringes forward and increases the internal system
pressure. Once a certain pressure threshold is reached, the
solenoid valve is opened, thus releasing the pressurised air
and generating an artificial cough.
In order to reproduce a coughing event, the three most
important variables are: volume, flow rate magnitude and
cough duration. The coughing experiments consist of three
stages:
1) In the first stage, a series of threshold pressures is tested
to characterise the relationship between flow rate and
threshold pressure. The acquired characterisation is used
to inform the following experiment, where the desired
flow rate magnitude is attained by setting the relative
pressure threshold.
2) In the second stage, the volume of the typical human
cough acquired in Section III is determined and a
simulation of a cough of similar air volume is performed,
hence volume is kept constant. The flow rate is also kept
constant.
3) In the third stage, the cough duration and maximum flow
rate (but not the total volume) are kept constant between
the physiological cough and the simulated one.
E. Results
Fig. 9 shows a monotonic relationship between pressure
threshold and flow rate magnitude. Fig. 10 shows internal
system pressure profile and flow rate for a typical simulated
cough. As soon as the threshold pressure (PT ) of 93.08 mbar
is reached, the solenoid valve is opened and this generates a
flow impulse of approximately 100ms followed by a tail of
lower flow for approximately 200ms.
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Fig. 9: Relationship between pressure threshold and flow rate
magnitude.
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Fig. 10: Correlation between internal system pressure profile
and flow rate.
In the constant volume tests (second stage, Fig. 12) the
simulator is able to replicate a cough event of comparable
volume to the physiological cough (Fig. 11). Although the
simulator cough profile is over a much longer duration, the
maximum flow rate of the two coughs is at 650 L/min.
The cough flow profile (Fig. 13) is most successfully
reproduced in the results of the third stage experiment, shown
in Fig. 14. In this case the total simulated cough event duration
(0.4s) is similar to the human subject one, but less high-
magnitude flow (0.1s-0.35s) is shown.
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Fig. 11: Human cough constant volume.
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Fig. 12: Simulator cough constant volume.
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Fig. 13: Human cough constant time.
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Fig. 14: Simulator cough constant time.
V. CONCLUSION
The robotic simulator presented in this work is able to
reproduce the frequency, tidal volume and amplitude of the
physiological flow rate profiles of breathing and deep breath-
ing. However, the novel simulator is not able to reproduce
the higher frequency flow artifacts present in the breathing
profiles observed. It cannot be excluded that some of the
artifacts observed in the physiological breathing profiles are
due to the compliant nature of the human respiratory system
and the characteristics and orientation of the muscles driving
the human diaphragm and chest. Regarding the coughing
simulation, the system described in this paper is able to
reproduce the volume, flow rate magnitude and duration of a
human cough. Also in this case, human cough profiles are not
exactly reproduced. A more advanced control system is being
prepared to tackle the issue. Also, it is possible that some of
those non-linearities are the result of the role of the larynx,
glottis and upper airway on coughing. Hence designing and
building soft robotic devices to mimic the naturally compliant
respiratory anatomy is one of our future aims to make our
platform even more suitable to testing and investigating the
human airway system.
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